Yarrow Bioscience, Inc. (YARW)
39.25
-0.25
(-0.63%)
USD |
NASDAQ |
Aug 25, 16:00
39.75
+0.50
(+1.27%)
Pre-Market: 09:17
Yarrow Bioscience Profit Margin (Quarterly) : -2.99K% for June 30, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.99K% |
| March 31, 2026 | -4.17K% |
| December 31, 2025 | -3.82K% |
| September 30, 2025 | -4.39K% |
| June 30, 2025 | -8.33K% |
| March 31, 2025 | -4.26K% |
| December 31, 2024 | -14.30K% |
| September 30, 2024 | -10.05K% |
| June 30, 2024 | -4.74K% |
| March 31, 2024 | -6.37K% |
| December 31, 2023 | -8.09K% |
| September 30, 2023 | -5.33K% |
| June 30, 2023 | -7.44K% |
| March 31, 2023 | -5.67K% |
| December 31, 2022 | -129.4K% |
| September 30, 2022 | -5.54K% |
| June 30, 2022 | -6.54K% |
| March 31, 2022 | -4.88K% |
| December 31, 2021 | -3.07K% |
| September 30, 2021 | -10.73K% |
| Date | Value |
|---|---|
| June 30, 2021 | -3.62K% |
| March 31, 2021 | -4.73K% |
| December 31, 2020 | -540.9% |
| September 30, 2020 | -756.0% |
| June 30, 2020 | -1.43K% |
| March 31, 2020 | -2.30K% |
| December 31, 2019 | -28.01K% |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | -4.94K% |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | -82.29% |
| March 31, 2018 | -2.55K% |
| December 31, 2017 | -334.3% |
| September 30, 2017 | -899.1% |
| June 30, 2017 | -1.37K% |
| March 31, 2017 | -1.22K% |
| December 31, 2016 | -1.07K% |
| September 30, 2016 | -1.52K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Oramed Pharmaceuticals, Inc. | -- |
| NRX Pharmaceuticals, Inc. | -1.50K% |
| ANI Pharmaceuticals, Inc. | 8.65% |
| Corcept Therapeutics, Inc. | 16.45% |
| Veru, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -64.87% |
| Return on Assets | -58.79% |
| Return on Invested Capital | -64.86% |
| Gross Profit Margin (Quarterly) | 93.81% |
| Operating Margin (Quarterly) | -3.20K% |
| Return on Net Operating Assets | -19.57K% |